List view / Grid view
10 June 2015 | By Victoria White
The treatment market for glaucoma will rise in value from $2.4 billion in 2013 to approximately $3 billion by 2023 across the seven major markets...
10 June 2015 | By Victoria White
New data shows that aerosol foam Enstilar provided rapid itch relief and improvements in itch-related sleep loss for patients suffering from psoriasis...
10 June 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, has announced the successful completion of an Enabled-First-in-Human® (Enabled-FIH) program for US biotech company Corcept Therapeutics Incorporated...
10 June 2015 | By Victoria White
Bristol-Myers Squibb has announced that data from the Orencia Phase 3b AVERT and AMPLE trials will be presented in during the EULAR 2015...
10 June 2015 | By Victoria White
Bayer has entered into a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd., for EUR 1,022 million...
10 June 2015 | By Victoria White
The FDA has granted Breakthrough Therapy designation status to Roche’s ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc)...
10 June 2015 | By Victoria White
Data presented at EULAR 2015 show that the effectiveness of Celltrion’s biosimilar infliximab was similar to the RMP in rheumatoid arthritis...
10 June 2015 | By Victoria White
UBM EMEA, organiser of CPhI South East Asia and CPhI Japan, has celebrated the closing of two growing Asian events that took place in April this year...
9 June 2015 | By GE
At the ACHEMA 2015 trade show in Frankfurt, GE showcases applications for use in Asset Performance Management (APM) in the chemical and process industries...
9 June 2015 | By Coulter Partners
Coulter Partners is pleased to announce the appointment of Shawn O’Connor as a Managing Director of their US business...
9 June 2015 | By NICE
NICE has recommended the anti-blood clotting drug apixaban as an option for treating and preventing venous thromboembolism (VTE) in adults...
9 June 2015 | By Victoria White
Carbylan Therapeutics has completed enrollment of its COR1.1 Phase 3 pivotal trial of Hydros-TA for the treatment of pain associated with osteoarthritis...
9 June 2015 | By Victoria White
Johnson & Johnson and a group of leading research organisations are launching the OPTICS Project - Open Translational Science in Schizophrenia...
9 June 2015 | By Victoria White
UBM EMEA announced the findings of the Pharma Insights Turkey 2015 report, a comprehensive review of the Turkish pharma market, at CPhI Istanbul...
9 June 2015 | By Victoria White
Results of the ELIXA study assessing the cardiovascular safety of lixisenatide in adults with type 2 diabetes and high CV risk have been presented...
